Myasthenia gravis: open trials in France

23 open trials have a site in France. Registry data; only the trial team decides who can take part.

NCT07463521
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
Trial Treatment · Phase 3 · UCB Biopharma SRL
Centre Hospitalier Universitaire de Dijon, Dijon · Centre Hospitalier Universitaire De Lille, Lille Cedex · Centre Hospitalier Regional De Marseille, Marseille · Centre Hospitalier Universitaire De Montpellier, Montpellier Cedex 5 · Centre Hospitalier Universitaire de Nantes, Nantes · Centre Hospitalier Universitaire de Nice, Nice · Fondation A. de Rothschild, Paris · Centre Hospitalier National d'Ophtalmologie des Quize-Vingts, Paris · Centre Hospitalier Universitaire de Toulouse, Toulouse
Registry updated 2026-11-06
NCT07465289
A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
Trial Treatment · Phase 3 · UCB Biopharma SRL
Centre Hospitalier Universitaire de Dijon, Dijon · Centre Hospitalier Universitaire De Lille, Lille Cedex · Centre Hospitalier Regional De Marseille, Marseille · Centre Hospitalier Universitaire De Montpellier, Montpellier Cedex 5 · Centre Hospitalier Universitaire de Nantes, Nantes · Centre Hospitalier Universitaire de Nice, Nice · Centre Hospitalier National d'Ophtalmologie des Quize-Vingts, Paris · Fondation A. de Rothschild, Paris · Centre Hospitalier Universitaire de Toulouse, Toulouse
Registry updated 2026-11-06
NCT04951622
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hospices Civils de Lyon, Bron · Centre Hospitalier Universitaire de Nice, Nice · Hopitaux Universitaires Pitie Salpetriere, Paris Cedex 13
Registry updated 2026-11-05
NCT07323316
Holistic Assessment and Remote Digital MONitoring of mYasthenia Gravis Via MyoSense 360
Trial Treatment · Ad scientiam
CHU de Brest La Cavale Blanche, Brest · CH Raymond Poincaré, Garches · CHRU de Nancy, Nancy · CHU Nantes, Nantes · CHU de Nice - Hôpital Pasteur 2, Nice · Hopital Hautepierre, Strasbourg · Hopital Pierre Paul Riquet, Toulouse
Registry updated 2026-11-05
NCT05374590
Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis
Trial Treatment · Phase 2/3 · argenx
Centre Hospitalier Regional De Marseille, Marseille · Hopital Necker Enfants Malades, Paris
Registry updated 2026-11-03
NCT07647510
A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
Trial Treatment · Phase 3 · Dianthus Therapeutics
Assistance Publique Hopitaux De Paris, Garches · Centre Hospitalier Universitaire de Nice, Nice · Assistance Publique Hopitaux de Paris, Paris
Registry updated 2026-10-30
NCT06987539
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
Trial Treatment · Phase 2 · Amgen
Assistance Publique Hopitaux de Paris, Paris
Registry updated 2026-10-23
NCT06463587
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Trial Treatment · Phase 3 · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Hospices Civils de Lyon, Bron · Chu Gabriel Montpied, Clermont-Ferrand · Assistance Publique Hopitaux De Paris, Creteil · Centre Hospitalier Universitaire Grenoble Alpes, Grenoble Cedex 9 · Centre Hospitalier Universitaire De Lille, Lille Cedex · Centre Hospitalier Universitaire de Nice, Nice · Fondation A. de Rothschild, Paris · Assistance Publique Hopitaux De Paris, Paris Cedex 13 · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2
Registry updated 2026-10-21
NCT06392386
A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
Trial Treatment · Phase 2/3 · argenx
Centre Hospitalier Regional De Marseille, Marseille
Registry updated 2026-09-28
NCT07072988
Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod
Trial Treatment · Phase 4 · Centre Hospitalier Universitaire de Nice
Hopital Henri Mondor, Créteil · Hôpital Raymond Pointcarré, Garches · CHU de Grenoble, Grenoble · Hopital Roger Salengro, Lille · CHU de la Timone, Marseille · CHRU de Nancy, Nancy · CHU de Nice, Nice · CHU Charles Nicolle, Rouen · CHU de Toulouse, Toulouse
Registry updated 2026-09-03
NCT07411963
Evaluation of the Condition of Patients Receiving EARLY Ravulizumab and Admitted in ICU for gMG Crisis
Research · Centre Hospitalier Universitaire de Nice
Hospices Civils de Lyon, Bron · Hôpital Raymond Pointcarré, Garches · APHP, Le Kremlin-Bicêtre · CHU de Lille, Lille · CHU de la Timone, Marseille · CHU de Nice, Nice · Hopitaux Universitaires de Strasbourg, Strasbourg · CHU Pierre Paul Riquet, Toulouse
Registry updated 2026-09-01
NCT07570589
Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)
Research · Centre Hospitalier Universitaire de Nice
CHU d Angers, Angers · CH de Boulogne-sur-Mer, Boulogne-sur-Mer · Hopital Henri Mondor, Créteil · Hôpital Raymond Pointcarré, Garches · CHU de Grenoble, Grenoble · GHICL Saint Vincent de Paul, Lille · CHU de Lille, Lille · CHU Dupuytren 1, Limoges · CHU de Nice, Nice · CHU Charles Nicolle, Rouen · CHU de Toulouse, Toulouse
Registry updated 2026-09-01
NCT06414954
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Trial Treatment · Phase 2 · NMD Pharma A/S
Centre de référence des maladies neuromusculaires AOC-CHU de Bordeaux - Hôpital Pellegrin, Bordeaux · Centre de Référence des Maladies Neuromusculaires et de la SLA, Marseille · Centre Hospitalier Universitaire de Nantes - Hôtel Dieu Centre de Référence des Maladies Neuromusculaires Rares -, Nantes · Unité de Recherche Clinique NeuroSciences, Nice · CHU de Nice, Nice
Registry updated 2026-08-21
NCT07677852
Sexual and Urinary Dysfunctions in Generalized Myasthenia
Research · Centre Hospitalier Universitaire de Nice
Nice University Hospital, Nice · APHP and Myology institute, Paris
Registry updated 2026-07-01
NCT06866652
Evaluating Dyspnea in Autoimmune Myasthenia Gravis "Why am I Short of Breath?"
Research · Institut de Myologie, France
Institute of Myology, Paris
Registry updated 2026-05-08
NCT06312644
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Research · Alexion Pharmaceuticals, Inc.
Paris
Registry updated 2026-04-16
2023-507539-40-00
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients with Myasthenia Gravis
Trial Treatment · Phase 2 · NMD Pharma A/S
Centre hospitalier Universitaire de Bordeaux, Bordeaux · Centre Hospitalier Regional De Marseille, Marseille · Centre Hospitalier Universitaire de Nantes, Nantes · Centre Hospitalier Universitaire de Nice, Nice
Registry updated 2026-02-26
NCT06342544
Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial.
Trial Treatment · Phase 3 · Fondation Ophtalmologique Adolphe de Rothschild
Centre hospitalier Universitaire de Bordeaux, Bordeaux · Hôpital Raymond Pointcarré, Garches · Centre Hospitalier Universitaire de Lille, Lille · Hospices Civils de Lyon, Lyon · Centre Hospitalier Universitaire de Nice, Nice · Centre Hospitalier Sainte-Anne, Paris · Fondation Adolphe de Rothschild, Paris · Hôpital de la Pitié-Salpêtrière, Paris · CHNO, Paris · Les Hopitaux Universitaires de Strasbourg, Strasbourg · Centre Hospitalier Universitaire de Toulouse, Toulouse
Registry updated 2026-01-21
NCT06815133
Effectiveness and Safety of Zilucoplan Treatment for French Patients With Myasthenia Gravis Over 3 Months
Research · Centre Hospitalier Universitaire de Nice
CHU Nice, Nice
Registry updated 2025-12-03
NCT07125105
Integrating Art Therapy and Adapted Physical Activity: Toward Improved Quality of Life in Patients With Myasthenia Gravis
Trial Treatment · Universite du Littoral Cote d'Opale
Lille University Hospital, Lille
Registry updated 2025-08-15
2023-506656-24-00
Immediate corticosteroid therapy and rituximab to prevent generalization in ocular myasthenia gravis: a PROBE-type multicenter, open-label, randomized controlled trial
Trial Treatment · Phase 3 · Hopital Fondation Adolphe De Rothschild
Centre hospitalier Universitaire de Bordeaux, Bordeaux · Hospices Civils de Lyon, Bron · Assistance Publique Hopitaux De Paris, Garches · Centre Hospitalier Universitaire De Lille, Lille Cedex · Centre Hospitalier Universitaire de Nice, Nice · Centre Hospitalier Sainte Anne Paris, Paris · Quinze-Vingts National Ophthalmology Hospital, Paris · Hopital Fondation Adolphe de Rothschild, Paris · Assistance Publique Hopitaux De Paris, Paris Cedex 13 · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2 · Centre Hospitalier Universitaire de Toulouse, Toulouse
Registry updated 2025-06-06
NCT05564936
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
Trial Treatment · Ad scientiam
Hôpital Raymond-Poincaré, Garches · Chu Grenoble, Grenoble · Hôpital Salengro, Lille · CHRU Nancy, Nancy · CHU Nantes, Nantes · Pitié-Salpêtrière, Paris · CHU de Strasbourg Hôpital de Hautepierre, Strasbourg · CHU Toulouse, Toulouse
Registry updated 2025-04-11
NCT06877403
Prevalence and Impact of Fatigue in Myasthenic Patients Followed At Clermont-Ferrand University Hospital - "My" Asthenia
Research · University Hospital, Clermont-Ferrand
CHU Clermont-Ferrand, Clermont-Ferrand
Registry updated 2025-03-14

All Myasthenia gravis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error